Long-acting Reversible Contraceptives Market
This report contains market size and forecasts of Long-acting Reversible Contraceptives (LARCs) i ... Read More
This report contains market size and forecasts of Hormonal Intrauterine Devices in global, including the following market information:
Global Hormonal Intrauterine Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hormonal Intrauterine Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hormonal Intrauterine Devices companies in 2021 (%)
The global Hormonal Intrauterine Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
13mg Hormonal Intrauterine Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hormonal Intrauterine Devices include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hormonal Intrauterine Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hormonal Intrauterine Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hormonal Intrauterine Devices Market Segment Percentages, by Type, 2021 (%)
13mg Hormonal Intrauterine Devices
19mg Hormonal Intrauterine Devices
52mg Hormonal Intrauterine Devices
Global Hormonal Intrauterine Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hormonal Intrauterine Devices Market Segment Percentages, by Application, 2021 (%)
Age 20-24
Age 25-34
Age 35-44
Others
Global Hormonal Intrauterine Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hormonal Intrauterine Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hormonal Intrauterine Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hormonal Intrauterine Devices revenues share in global market, 2021 (%)
Key companies Hormonal Intrauterine Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hormonal Intrauterine Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Merck
Cooper Companies
AbbVie Allergan
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
This report contains market size and forecasts of Long-acting Reversible Contraceptives (LARCs) i ... Read More
This report contains market size and forecasts of Aseptic Sampling Devices in global, including t ... Read More
This report contains market size and forecasts of Tubal Rings and Clips in global, including the ... Read More
This report contains market size and forecasts of Hormonal Contraceptive Implant in global, inclu ... Read More